Spectral Diagnostics Incorporated Company Profile

22:34 EDT 25th July 2016 | BioPortfolio

Spectral Diagnostics Inc. remains dedicated to being the leader in the research, development and commercialization of decision point diagnostics. Our commitment to the development of new and novel rapid tests, such as the patented Cardiac Panel™, reagents and membranes, distinguishes the Company's approach to the diagnosis of cardiac and other serious conditions at the medical decision point. Spectral is a Canadian publicly traded company incorporated in 1991 with operations in Canada, the United States and Europe. Spectral's products are available worldwide


111 Pencader Drive
United States of America


Phone: 302 456 6789
Fax: 416 626 7383

News Articles [498 Associated News Articles listed on BioPortfolio]

Spectral Medical secures $10M for clinical trial looking to improve sepsis diagnostics

Sepsis is a difficult condition to accurately diagnose once symptoms appear. For this reason, Spectral Medical is taking recent funding to further development of its devices designed to detect endotox...

University Medical Center Utrecht expands diagnostic capabilities with Philips IQon spectral CT system

Royal Philips announced the installation of its IQon Spectral CT, the industry’s first spectral detector-based Computed Tomography (CT) at the University Medical Center Utrecht (UMC Utrecht). The Ph...

Funding round stretched by Spectral Medical to $10.5M

An additional 806,804 shares have been sold by Toronto-based Spectral Medical from an overallotment option on its recent fina -More- 

Spectral imaging technologies in microscopy: an interview with Alex Cooper

Spectral imaging encompasses two types of light control when using a microscope. Conventional microscopes use fluorescence excitation and emission filters, matched to fluorescent probes, in order to v...

Spectral Medical completes enrollment for EUPHRATES clinical trial

TORONTO, ON – Spectral Medical Inc. reports that it has completed patient enrollment for its pivotal Phase 3 EUPHRATES clinical trial. The clinical trial is intended to demonstrate the safety an...

BRIEF-Spectral Medical Q1 revenue $1.5 million

* Spectral Medical Inc says revenue for three months ended march 31, 2016 was $1.5 million compared to $877,000 for same three month period last year Source text for Eikon: Further company coverage:...

BRIEF-Spectral Medical completes of enrolment for Euphrates trial

* Spectral Medical announces completion of enrolment for its pivotal Euphrates clinical trial Source text for Eikon: Further company coverage:

Spectral Medical gets $Cdn10mm in bought deal financing

Spectral Medical Inc. raised $Cdn10mm ($7mm) through a bought deal financing of 14.3mm common shares at $Cdn0.70. Funds will support the ongoing Phase III clinical trial of its Toraymyxin sepsis devic...

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]


Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [835 Associated PubMed Articles listed on BioPortfolio]

Spectral-temporal compressive imaging.

This Letter presents a compressive camera that integrates mechanical translation and spectral dispersion to compress a multi-spectral, high-speed scene onto a monochrome, video-rate detector. Experime...

The importance of test accuracy in economic evaluations of companion diagnostics.

Economic evaluations of companion diagnostics often fail to include the impact that tests have on the overall economic value of test-drug combinations. Methods: To illustrate the importance of test a...

Profile of the MP Diagnostics HTLV Blot 2.4 test: a supplemental assay for the confirmation and differentiation of antibodies to HTLV-1 and HTLV-2.

As the first US FDA-approved assay for supplemental HTLV testing, the MP Diagnostics HTLV Blot 2.4 is an effective and efficient method for confirming and differentiating HTLV type infection in repeat...

Concurrent spatial and spectral filtering by resonant nanogratings.

Optical devices incorporating resonant periodic layers constitute an emerging technological area. Recent advances include spectral filters, broadband mirrors, and polarizers. Here, we demonstrate conc...

Individual Human Brain Areas Can Be Identified from Their Characteristic Spectral Activation Fingerprints.

The human brain can be parcellated into diverse anatomical areas. We investigated whether rhythmic brain activity in these areas is characteristic and can be used for automatic classification. To this...

Clinical Trials [170 Associated Clinical Trials listed on BioPortfolio]

Spectral Diagnosis of Cutaneous Malignancy

The goal of this clinical research study is to evaluate the use of an imaging technology called spectral diagnosis. Researchers want to find out if a special spectral-diagnosis probe can ...

Ocular Imaging With Spectral Domain Optical Coherence Tomography

The purpose of this study is to analyze macular retinal thickness and macular volume using the spectral domain - optical coherence tomography (SD-OCT) in normal eyes and in eyes with vario...

Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies

The purpose of this study is to compare the newly released Spectral OCT/SLO (OTI, Toronto, Canada) with the Zeiss Stratus OCT (Carl-Zeiss Meditec, Dublin, CA) with regards to the quality o...

Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second Device

The overall objective of this study is to identify potential improvements for a noninvasive method of diagnosing dysplasia and neoplasia in the cervix using Multi-spectral Digital Colposco...

Validation of Bispectral Index (BIS)-Monitor in 3 Groups of Newborn Children

This study will evaluate the registration of the bispectral index and spectral edge frequency in relation to the behavioural state.

Companies [904 Associated Companies listed on BioPortfolio]

Spectral Diagnostics Incorporated

Spectral Diagnostics Inc. remains dedicated to being the leader in the research, development and commercialization of decision point diagnostics. Our commitment to the development of new and novel ra...

Spectral Diagnostics Inc.

Spectral Imaging Inc

Applied Spectral Imaging (ASI) is a leading provider of cytogenetics systems to prestigious clinical and research labs all over the world. Its CytoLabView suite offers a complete solution for all imag...

Applied Spectral Imaging (ASI)

Applied Spectral Imaging (ASI) makes patient care better through advanced biomedical imaging.

Spectral Genomics, Inc

Spectral Genomics BAC clone arrays provide a complete view of the genome allowing researchers to view the loci of chromosomal aberrations. The company has enabled this capability for the Human Genome ...

More Information about "Spectral Diagnostics Incorporated" on BioPortfolio

We have published hundreds of Spectral Diagnostics Incorporated news stories on BioPortfolio along with dozens of Spectral Diagnostics Incorporated Clinical Trials and PubMed Articles about Spectral Diagnostics Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Spectral Diagnostics Incorporated Companies in our database. You can also find out about relevant Spectral Diagnostics Incorporated Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record